LEPROSY Professor Jamal R Al-Rawi MBChB, MSc, FICMS Prof. of Comm. Med. & Dermatovenereology Dept of Comm. Med. College of Med. Al-Mustansiriya University.
Leprosy Hansen’s Disease Definition: Infectious agent: Mycobacterium Leprae Resistance Classification Viability Virulence Multiplications Inactivation Antigenicity
LEPROSY (Hansen’s Disease) Epidemiology A- Geographical Distribution B- Prevalence C- Age distribution D- Sex Distribution E- Occupation F- Seasonal Variation
LEPROSY- CLINICAL FORMS Closed case Open case Low infectivity High infectivity Paucibacillary Multibacillary TT BT BB BL LL Tuberculoid Leprosy Lepromatous leprosy Drug therapy WHO Strategy Stimulate CMI Prof. Dr Jamal R Al-Rawi, MBChB, MSc, FICMS
Transplacental transmission Percutaneous Transmission MODE OF TRANSMISSION Inhalation Transplacental transmission Percutaneous Transmission
Leprosy Hansen’s Disease Control Measures: Reporting Isolation of case until 6 successive cultures it become negative. Proper disinfection of the patients towels utensils etc. examination of the contact & screening for positive cases. Treatment of contacts by chemoprophylaxis Preventive Measures Improvement of living condition BCG vaccination Screening for cases in area with high prevalence & among risk groups Eradications of endemic foci.